Abstract:Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease with high prevalence and mortality. In some acute exacerbations of COPD (AECOPD) in patients with no obvious signs of infection, early antibiotic treatment seems to clinically improve the disease, but more studies are needed to determine the prognostic impact of antibiotic treatment in AECOPD patients with no obvious signs of infection. Purpose: To clarify the impact of antibiotic treatment on the short-term and long-term prognoses of AECOPD patients without obvious signs of infection. Methods: The impact of the two treatment methods on the prognosis of patients was compared at 30, 90, 180, and 360 days after discharge. A multicenter, randomized, parallel-controlled clinical trial was conducted in a department of respiratory and critical care medicine in Central China. All patients met the inclusion criteria for AECOPD, and the patients were randomly assigned to the antibiotic group or the nonantibiotic group at a 1:1 ratio. Patients in the antibiotic group were given moxifloxacin 400 mg/day intravenously for 7 days. Patients in the nonantibiotic group were intravenously injected with the same amount of normal saline as the amount of moxifloxacin given to those in the antibiotic group for 7 days. Results: There were 406 patients in the antibiotic group and 410 patients in the nonantibiotic group. During the short-term and long-term follow-ups, the acute exacerbation frequency, intensive care unit (ICU) treatment rate, mortality, and mMRC and CAT scores were not significantly different between the two groups ( p > 0.05). At the 180- and 360-day follow-ups, the forced expiratory volume in 1 s (FEV1%) and peak expiratory flow (PEF) were not significantly different between the two groups ( p > 0.05). The 30-day readmission rate was significantly lower in the antibiotic group than in the nonantibiotic group ( p < 0.05). The time from discharge to the first acute exacerbation was not significantly different between the two groups ( p > 0.05). The length of the first hospital stay after discharge was significantly lower in the antibiotic group (5.84 days) than in the nonantibiotic group (6.75 days) ( p < 0.05). At the 30-day follow-up, the acute exacerbation frequency, age, C-reactive protein (CRP) level, and sputum viscosity were significantly greater in the nonantibiotic group than in the antibiotic group ( p 62.5 years, with a CRP level >12.56 mg/L or with a sputum viscosity >III, in the nonantibiotic group than in those in the antibiotic group, suggesting that the short-term prognosis was poor. Conclusion: Patients who are >62.5 years of age, have a CRP concentration >12.56 mg/L, or have a sputum viscosity >III without obvious signs of infection should be treated with antibiotics to improve their short-term prognosis. Clinical Trial Registration:: (https://www.chictr.org.cn), (ChiCTR1800018921)

An Evaluation of Clinical Pulmonary Infection Score on the Course of Antimicrobial Therapy in Patients with Clinical Suspected Hospital Acquired Lower Respiratory Tract Infection

Study on the Clinical Pathway of Community Acquired Pneumonia

Impact of a Comprehensive Antimicrobial Stewardship Program on Antimicrobial Utilization and Clinical Isolates Distribution in ICUs

Improvement in detecting bacterial infection in lower respiratory tract infections using the Intensive Care Infection Score (ICIS)

A Multicenter Clinical Trial on the Efficacy and Safety of Piperacillin/tazobactam for the Treatment of Patients with Hospital Acquired Pneumonia: Treatment of Hospital Acquired Pneumonia Forum in Huadong Area.

Effect of Pulmonary Infection Score on Intervention to Selection of Antibiotics and Prognosis of the Elderly Patients with Severe Pneumonia

Analysis of Clinical Efficacy of Different Initial Antimicrobial Treatment in Healthcare Associated Pneumonia Patients in Emergency Department.

Deescalation Therapy for Severe Nosocomial Pneumonia and Clinical Using of Teicoplanin

Using Procalcitonin to Guide Antibiotic Escalation in Patients With Suspected Bacterial Infection: A New Application of Procalcitonin in the Intensive Care Unit

The value of serum procalcitonin in treatment of acute exacerbations of chronic obstructive pulmonary disease

Efficacy and Significance of Various Scores for Pneumonia Severity in the Management of Patients with Community-Acquired Pneumonia in China

[A Control Study on Bacterial Resistance and Clinical Features of Lower Respiratory Tract Infection with Pseudomonas Aeruginosa in Medical Intensive Care Unit and General Ward].

Clinical Analysis of Cathetei-Related Bloodstream Infection

Hospital-associated Pneumonia in a Respiratory Intensive Care Unit: Clinical Analysis

Risk Factors of Clinical Outcomes and Inadequate Initial Antibiotic Therapy with Pneumonia Caused by Pseudomonas Aeruginosa in Intensive Care Unit

The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study

Effect of comprehensive intervention measures on preventing and controlling multidrug-resistant organism infection/colonization in respiratory tract of intensive care unit patients

Ventilation Improvement after Pneumonia Treatment Evaluated with Electrical Impedance Tomography: an Observational Study.

Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae : a 4-year quasi-experimental before-and-after study

Epidemiology and Antimicrobial Resistance among Commonly Encountered Bacteria Associated with Infections and Colonization in Intensive Care Units in a University-Affiliated Hospital in Shanghai

Association of Antibiotic Utilization Measures with Control of Extended-spectrum β-lactamases